Delivery Order SPE2DB20D7059-SPE2DB25FGTM4
Award Date 9/26/25
Potential Completion Date 10/20/25
Potential Value $30K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mresvia 50 mcg/0.5 mL syringes with a ceiling value of $14,920.80. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of October 20, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a discrete procurement action under a larger federal contract vehicle...
- The Defense Logistics Agency (DLA) awarded a $1,492.08 delivery order to AmerisourceBergen Drug Corp for Mresvia 50 micrograms/0.5 milliliter syringes on September 26, 2025, with an ultimate completion date of October 20, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $6,344.46 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Aranest 40 MCG/0.4 ML syringes. This firm fixed-price, non-set-aside contract is scheduled for ultimate completion on September 18, 2025, with performance to occur at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. This...
- The Defense Logistics Agency awarded a delivery order valued at $9,531.48 to AmerisourceBergen Drug Corp for the supply of Imuldosa 90 mg/ml syringes on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency has awarded a $6,210.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 3 mL syringes. The contract, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, will be performed in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 vehicle designated SPE2DX and...
- The Defense Logistics Agency awarded a delivery order valued at $2,096.82 to AmerisourceBergen Drug Corp for the provision of 10 mg/ml disposable syringes in 0.55ml quantities. The contract employs firm fixed pricing and was competitively awarded without set-aside provisions. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $40,959.52 to AmerisourceBergen Drug Corp on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injections valued at $6,422.82, with completion expected by September 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $54,083.66 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on September 12, 2025. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $39,149.57 to AmerisourceBergen Drug Corp on August 22, 2025, with an ultimate completion date of the same date. This firm fixed-price delivery order represents a non-competitive award under a larger indefinite delivery contract vehicle and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...